Products
Tildipirosin is commercially available as a solution for injection. The drug was approved in many countries in 2013.
Structure and properties
Tildipirosin (C41H71N3O8, Mr = 734.0 g/mol) is a 16-membered semisynthetic macrolide antibiotic.
Effects
Tildipirosin (ATCvet QJ01FA96) has bacteriostatic to bactericidal properties. The effects are due to inhibition of protein synthesis by binding to ribosomal bacterial RNA.
Indications
For the treatment of swine respiratory disease (SRD) associated with tildipirosin-sensitive , , and .
